A comprehensive study of polymorphic sites along the HLA-G gene: Implication for gene regulation and evolution

Molecular Biology and Evolution

Volumn 28, Issue 11, 2011, Pages 3069-3086

  Castelli, Erick C ^a   Mendes Junior, Celso T ^b   Veiga Castelli, Luciana C ^b   Roger, Michel ^c   Moreau, Philippe ^d   Donadi, Eduardo A ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Inst Univ d'Hématologie   (France)

Author keywords

Brazilians; haplotypes; HLA G, 5 upstream regulatory region (5 URR); polymorphism; promoter, 3 untranslated region (3 UTR)

Indexed keywords

HLA G ANTIGEN;

3' UNTRANSLATED REGION; 5' UPSTREAM REGULATORY REGION; ARTICLE; BONE MARROW; BRAZIL; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; MOLECULAR EVOLUTION; NORMAL HUMAN; ORGAN DONOR; POLYMERASE CHAIN REACTION; PROMOTER REGION; RNA STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; BRAZIL; DNA PRIMERS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; GENETIC VARIATION; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 80155195725     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msr138     Document Type: Article

References (92)

1. Aldrich C, Wambebe C, Odama L, Di Rienzo A, Ober C. 2002. Linkage disequilibrium and age estimates of a deletion polymorphism (1597DeltaC) in HLA-G suggest non-neutral evolution. Hum Immunol. 63:405-412.
2. Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Ellis SA, McMichael AJ, Braud VM. 1999. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med. 189:1149-1156.
3. Alvarez M, Piedade J, Balseiro S, Ribas G, Regateiro F. 2009. HLA-G 3'-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations. Int J Immunogenet. 36:361-366.
4. Archie EA, Henry T, Maldonado JE, Moss CJ, Poole JH, Pearson VR, Murray S, Alberts SC, Fleischer RC. 2010. Major histocompatibility complex variation and evolution at a single, expressed DQA locus in two genera of elephants. Immunogenetics 62:85-100.
5. Auboeuf D, Honig A, Berget SM, O'Malley BW. 2002. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298:416-419.
6. Bamshad MJ, Mummidi S, Gonzalez E, et al. (8 co-authors). 2002. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc Natl Acad Sci U S A. 99:10539-10544.
7. Bandelt HJ, Forster P, Sykes BC, Richards MB. 1995. Mitochondrial portraits of human populations using median networks. Genetics 141:743-753.
8. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
9. Berger DS, Hogge WA, Barmada MM, Ferrell RE. 2010. Comprehensive analysis of HLA-G: Implications for recurrent spontaneous abortion. Reprod Sci. 17:331-338.
10. Bettencourt BF, Santos MR, Fialho RN, et al. (8 co-authors). 2008. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics. 9:68.
11. Brown D, Trowsdale J, Allen R. 2004. The LILR family: Modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens. 64:215-225.
12. Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J. 2008. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111:4862-4870.
13. Carosella ED, Horuzsko A. 2007. HLA-G and cancer. Semin Cancer Biol. 17:411-412.
14. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. 2008. HLA-G: From biology to clinical benefits. Trends Immunol. 29:125-132.
15. Castelli EC, Mendes-Junior CT, Deghaide NH, de Albuquerque RS, Muniz YC, Simoes RT, Carosella ED, Moreau P, Donadi EA. 2010. The genetic structure of 3'untranslated region of the HLA-G gene: Polymorphisms and haplotypes. Genes Immun. 11:134-141.
16. Castelli EC, Mendes-Junior CT, Donadi EA. 2007. HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens. 70:62-68.
17. Castelli EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA. 2008. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens. 72:149-157.
18. Castelli EC, Mendes-Junior CT, Wiezel CE, Peres NT, Simoes AL, Rossi NM, Donadi EA. 2007. A novel HLA-G allele, HLA-.G.*010111, in the Brazilian population. Tissue Antigens. 70:349-350.
19. Castelli EC, Moreau P, Oyae Chiromatzo A, Mendes-Junior CT, Veiga- Castelli LC, Yaghi L, Giuliatti S, Carosella ED, Donadi EA. 2009. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol. 70:1020-1025.
20. Castro MJ, Morales P, Martinez-Laso J, Allende L, Rojo-Amigo R, Gonzalez-Hevilla M, Varela P, Moreno A, Garcia-Berciano M, Arnaiz-Villena A. 2000. Evolution of MHC-G in humans and primates based on three new 3'UT polymorphisms. Hum Immunol. 61:1157-1163.
21. Chu W, Gao J, Murphy WJ, Hunt JS. 1999. A candidate interferongamma activated site (GAS element) in the HLA-G promoter does not bind nuclear proteins. Hum Immunol. 60:1113-1118.
22. Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda P, Crisa L. 2006. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55:1214-1222.
23. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1809-1818.
24. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:3096-3100.
25. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282.
26. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. 1997. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med. 186:289-298.
27. Diehl M, Munz C, Keilholz W, Stevanovic S, Holmes N, Loke YW, Rammensee HG. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol. 6:305-314.
28. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. 2011. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci. 68:369-395.
29. Excoffier L, Laval G, Schneider S. 2005. Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online. 1:47-50.
30. Excoffier L, Slatkin M. 1998. Incorporating genotypes of relatives into a test of linkage disequilibrium. Am J Hum Genet. 62:171-180.
31. Flajollet S, Poras I, Carosella ED, Moreau P. 2009. RREB-1 is a transcriptional repressor of HLA-G. J Immunol. 183:6948-6959.
32. Gobin SJ, Biesta P, de Steenwinkel JE, Datema G, van den Elsen PJ. 2002. HLA-G transactivation by cAMP-response elementbinding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J Biol Chem. 277:39525-39531.
33. Gobin SJ, Keijsers V, van Zutphen M, van den Elsen PJ. 1998. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol. 161:2276-2283.
34. Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ. 1999. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol. 163:1428-1434.
35. Guo SW, Thompson EA. 1992. Performing the exact test of Hardy- Weinberg proportion for multiple alleles. Biometrics 48:361-372.
36. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. 1993. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet. 2:2200.
37. Hiby SE, King A, Sharkey A, Loke YW. 1999. Molecular studies of trophoblast HLA-G: Polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens. 53:1-13.
38. Hughes AL, Nei M. 1989. Nucleotide substitution at major histocompatibility complex class II loci: Evidence for overdominant selection. Proc Natl Acad Sci U S A. 86:958-962.
39. Hviid TV. 2006. HLA-G in human reproduction: Aspects of genetics, function and pregnancy complications. Hum Reprod Update. 12:209-232.
40. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. 2003. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55:63-79.
41. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. 2004. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 56:135-141.
42. Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. 2006. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL- 10 expression. Hum Immunol. 67:53-62.
43. Ibrahim EC, Morange M, Dausset J, Carosella ED, Paul P. 2000. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chaperones. 5:207-218.
44. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE. 2003. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 171:1376-1384.
45. Ito T, Ito N, Saathoff M, Stampachiacchiere B, Bettermann A, Bulfone-Paus S, Takigawa M, Nickoloff BJ, Paus R. 2005. Immunology of the human nail apparatus: The nail matrix is a site of relative immune privilege. J Invest Dermatol. 125:1139-1148.
46. Kang H, Yun HS, Song MY, Lee JK, Kwack K. 2007. Identification of novel HLA-G subtype, HLA-.G.*0109, by sequencing in the Korean population. Tissue Antigens. 70:529-530.
47. Klein J, Sato A. 2000a. The HLA system. First of two parts. N Engl J Med. 343:702-709.
48. Klein J, Sato A. 2000b. The HLA system. Second of two parts. N Engl J Med. 343:782-786.
49. Kuersten S, Goodwin EB. 2003. The power of the 3' UTR: Translational control and development. Nat Rev Genet. 4:626-637.
50. Lajoie J, Boivin AA, Jeanneau A, Faucher MC, Roger M. 2009. Identification of six new HLA-G alleles with non-coding DNA base changes. Tissue Antigens. 73:379-380.
51. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G. 2007. PyPop update-a software pipeline for large-scale multilocus population genomics. Tissue Antigens: 69(Suppl 1): 192-197.
52. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED. 2003. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol. 64:1039-1044.
53. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol. 11:1351-1356.
54. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity. 3:591-600.
55. Lefebvre S, Berrih-Aknin S, Adrian F, Moreau P, Poea S, Gourand L, Dausset J, Carosella ED, Paul P. 2001. A specific interferon (IFN)- stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem. 276:6133-6139.
56. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. 2004. HLAG1- expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A. 101:7064-7069.
57. Librado P, Rozas J. 2009. DnaSP v5: A software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25:1451-1452.
58. Mallet V, Blaschitz A, Crisa L, Schmitt C, Fournel S, King A, Loke YW, Dohr G, Le Bouteiller P. 1999. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol. 11:889-898.
59. Mendes-Junior CT, Castelli EC, Simoes RT, Simoes AL, Donadi EA. 2007. HLA-G 14-bp polymorphism at exon 8 in Amerindian populations from the Brazilian Amazon. Tissue Antigens. 69:255-260.
60. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N. 2004. Erythroblasts secrete the nonclassical HLAG molecule from primitive to definitive hematopoiesis. Blood 104:3153-3160.
61. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
62. Moreau P, Flajollet S, Carosella ED. 2009. Nonclassical transcriptional regulation of HLA-G: An update. J Cell Mol Med. 13(9B):2973-2989.
63. Moreau P, Mouillot G, Rousseau P, Marcou J, Dausset C, Carosella ED. 2003. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci U S A. 100:1191-1196.
64. Mouillot G, Marcou C, Rousseau P, Rouas-Freiss N, Carosella ED, Moreau P. 2005. HLA-G gene activation in tumor cells involves cis-acting epigenetic changes. Int J Cancer. 113:928-936.
65. Nicolae D, Cox NJ, Lester LA, et al. (19 co-authors). 2005. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet. 76:349-357.
66. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, Moreau P. 2001. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: Possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci. 58:1943-1949.
67. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. 2003. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet. 72:1425-1435.
68. Ober C, Billstrand C, Kuldanek S, Tan Z. 2006. The miscarriageassociated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod. 21:1743-1748.
69. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. 2003. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A. 100:177-182.
70. Pirri A, Contieri FC, Benvenutti R, Bicalho Mda G. 2009. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl Immunol. 20:143-149.
71. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A. 96:5674-5679.
72. Pyo CW, Williams LM, Moore Y, Hyodo H, Li SS, Zhao LP, Sageshima N, Ishitani A, Geraghty DE. 2006. HLA-E, HLA-F, and HLA-G polymorphism: Genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes. Immunogenetics 58:241-251.
73. Rajagopalan S, Long EO. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 189:1093-1100.
74. Ramalho RF, Santos EJ, Guerreiro JF, Meyer D. 2010. Balanced polymorphism in bottlenecked populations: The case of the CCR5 5' cis-regulatory region in Amazonian Amerindians. Hum Immunol. 71:922-928.
75. Raymond M, Rousset F. 1995. GENEPOP (version 1.2): Population genetics software for exact tests and ecumenicism. J Hered. 86:248-249.
76. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse- Wilde H. 2001. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens. 57:15-21.
77. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. 2005. Tolerization of dendritic cells by HLA-G. Eur J Immunol. 35:1133-1142.
78. Rizzo R, Hviid TV, Govoni M, et al. (13 co-authors). 2008. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens. 71:520-529.
79. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. 1997. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A. 94:11520-11525.
80. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. 2003. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol. 64:1005-1010.
81. Sabeti PC, Walsh E, Schaffner SF, et al. (12 co-authors). 2005. The case for selection at CCR5-Delta32. PLoS Biol. 3:e378.
82. Sachidanandam R, Weissman D, Schmidt SC, et al. (38 co-authors). 2001. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933.
83. Schmidt CM, Ehlenfeldt RG, Athanasiou MC, Duvick LA, Heinrichs H, David CS, Orr HT. 1993. Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription. J Immunol. 151:2633-2645.
84. Shi Y, Sawada J, Sui G, Affar el B, Whetstine JR, Lan F, Ogawa H, Luke MP, Nakatani Y. 2003. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422:735-738.
85. Solier C, Mallet V, Lenfant F, Bertrand A, Huchenq A, Le Bouteiller P. 2001. HLA-G unique promoter region: Functional implications. Immunogenetics 53:617-625.
86. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 68:978-989.
87. Tan Z, Randall G, Fan J, et al. (9 co-authors). 2007. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet. 81:829-834.
88. Tan Z, Shon AM, Ober C. 2005. Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet. 14:3619-3628.
89. Veit TD, Chies JA. 2009. Tolerance versus immune response-microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol. 20:229-231.
90. Yelavarthi KK, Schmidt CM, Ehlenfeldt RG, Orr HT, Hunt JS. 1993. Cellular distribution of HLA-G mRNA in transgenic mouse placentas. J Immunol. 151:3638-3645.
91. Yie SM, Li LH, Xiao R, Librach CL. 2008. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod. 14:649-653.
92. Yie SM, Xiao R, Librach CL. 2006. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod. 21:2538-2544.